Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
出版年份 2018 全文链接
标题
Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-11-20
DOI
10.1111/dom.13592
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro
- (2018) Peter Breining et al. DIABETES OBESITY & METABOLISM
- Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls
- (2018) Lars C. Gormsen et al. DIABETES OBESITY & METABOLISM
- Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression
- (2018) Xiaopeng Zhu et al. Lipids in Health and Disease
- Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes
- (2018) Edith Pascale Mofo Mato et al. MEDICINE
- The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action
- (2018) Piotr Zabielski et al. Scientific Reports
- Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice
- (2018) Alexandre Abilio de Souza Teixeira et al. INFLAMMOPHARMACOLOGY
- AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
- (2018) Nadia Boudaba et al. EBioMedicine
- Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
- (2018) S.R. Sharpton et al. Clinical Gastroenterology and Hepatology
- Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
- (2018) Roger W. Hunter et al. NATURE MEDICINE
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin
- (2017) Emma Henriksson et al. JOURNAL OF BIOLOGICAL RHYTHMS
- Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice
- (2017) London Allen et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention
- (2017) Yue Zhang et al. LIFE SCIENCES
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
- (2017) Tomasz Kostrzewski et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway
- (2017) Min-Jie Lin et al. Oncotarget
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
- (2017) Ichiro Tokubuchi et al. PLoS One
- Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation
- (2016) Lucie Hyrsova et al. DRUG METABOLISM REVIEWS
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Metformin increases hepatic leptin receptor and decreases steatosis in mice
- (2016) Xuemei Tang et al. JOURNAL OF ENDOCRINOLOGY
- Current understanding of metformin effect on the control of hyperglycemia in diabetes
- (2016) Hongying An et al. JOURNAL OF ENDOCRINOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21
- (2016) Eun Kyung Kim et al. MEDIATORS OF INFLAMMATION
- Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
- (2015) Rebecca J. Ford et al. BIOCHEMICAL JOURNAL
- The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet
- (2015) Edyta Maslak et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats
- (2015) Frank A Duca et al. NATURE MEDICINE
- New mechanisms of metformin action: Focusing on mitochondria and the gut
- (2015) Kyu Yeon Hur et al. Journal of Diabetes Investigation
- Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
- (2014) Young Mi Song et al. Autophagy
- Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
- (2014) Filipe De Vadder et al. CELL
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Interactions Between the Intestinal Microbiome and Liver Diseases
- (2014) Bernd Schnabl et al. GASTROENTEROLOGY
- Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
- (2014) Shih-Lung Woo et al. PLoS One
- Effects of metformin on weight loss
- (2014) Steven K. Malin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein
- (2013) FANG LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Giridhar Kanuri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Metformin trims fats to restore insulin sensitivity
- (2013) Reuben J Shaw NATURE MEDICINE
- Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
- (2013) Morgan D Fullerton et al. NATURE MEDICINE
- The genetics of NAFLD
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Animal clocks: when science meets nature
- (2013) N. Kronfeld-Schor et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association
- (2012) Naga Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner
- (2012) Maayan Barnea et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- Dorothy Hodgkin Lecture 2012* Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management
- (2012) C. D. Byrne DIABETIC MEDICINE
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Species differences in drug transporters and implications for translating preclinical findings to humans
- (2012) Xiaoyan Chu et al. Expert Opinion on Drug Metabolism & Toxicology
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
- (2012) Yuki Kita et al. PLoS One
- Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction
- (2011) Jeffrey D Browning et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations
- (2011) Jean-Daniel Lalau et al. CLINICAL DRUG INVESTIGATION
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
- (2011) R. M. Williamson et al. DIABETES CARE
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
- (2011) Scott B. Reeder et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
- (2011) Elena Sofer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
- (2009) Ziya Omer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
- (2009) William W. Shields et al. Therapeutic Advances in Gastroenterology
- The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
- (2008) A. Nar et al. ACTA DIABETOLOGICA
- Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
- (2008) R. IDILMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now